Our experience on the ground in Africa
We have extensive experience and key strategic partnerships across the African continent. In partnership with our main partner , a CRO operating right across Africa, we bring expertise in more than 27 African countries with specialties in infectious diseases, sickle-cell anemia, and oncology.
-
27 African and Middle East countries
-
28,000+ patients
-
25 + years’ experience in Africa
HIV experience
-
30+ HIV studies
-
13,800 HIV patients and healthy volunteers
-
450+ sites globally
Investing in Anti-HIV
How HIV therapeutic developers can reshape the future of HIV control.
This whitepaper looks at the significant advancements in the management of human immunodeficiency virus (HIV) over the past decade and where treatment is going in the decade ahead.
Malaria
More than 25 years ago, we began working with the US Army in Kenya to aid in development of treatments and preventions for malaria. Building on that platform, we continue to participate in clinical trial operations, and training to support disease surveillance, for the US government, NGOs, and Biopharma.
With offices in key locations in West Africa, and our network of accredited laboratories, clinical research sites and strategic partners throughout Sub-Saharan Africa, 91黑料 can provide staff on the ground, providing rapid site selection, initiation, and staff training and patient enrolment in a total of 27 African countries and Middle East countries.
Ebola virus disease
Our longstanding relationships within sub-Saharan Africa uniquely positioned us to be on the ground in the 2014 Ebola hotzone. Our work related to Ebola Virus Disease (EVD) continues with longitudinal studies of EVD survivors and their communities.